Triple

T22404657
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EU) No 536/2014 E553848 entity
Predicate relevantAuthority P148031 FINISHED
Object European Medicines Agency E3950 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Medicines Agency | Statement: [Regulation (EU) No 536/2014, relevantAuthority, European Medicines Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: European Medicines Agency
Context triple: [Regulation (EU) No 536/2014, relevantAuthority, European Medicines Agency]
  • A. European Medicines Agency chosen
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • B. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • C. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • D. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: relevantAuthority
Context triple: [Regulation (EU) No 536/2014, relevantAuthority, European Medicines Agency]
  • A. legalAuthorityIn
    Indicates that an entity holds official legal power, jurisdiction, or governing authority within a specified area or domain.
  • B. hasLegalRelevanceIn
    Indicates that something is legally significant, applicable, or has consequences within a specified legal context, case, or jurisdiction.
  • C. claimedAuthorityFrom
    Indicates that one entity asserts its authority, legitimacy, or right to act is derived from another specified source or entity.
  • D. authorityBasedOn
    Indicates that one entity’s authority or power is derived from, justified by, or contingent upon another specified basis or source.
  • E. legalAuthorityOver
    Indicates that one entity has the recognized power or right to make, enforce, or adjudicate rules or decisions concerning another entity.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e4da7048190b4387d422a9a0de5 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f158b6762c8190991fc14c5ca8e609 completed April 29, 2026, 1:02 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0ae9cfabe081908d6a001bcfe5372c completed May 18, 2026, 10:28 a.m.
PD Predicate disambiguation batch_69e8989495bc81909d2699fce5992e28 completed April 22, 2026, 9:44 a.m.
PDg Predicate description generation batch_69e8aa39e3388190b659d59948ebf3e6 completed April 22, 2026, 11 a.m.
Created at: April 16, 2026, 8:46 p.m.